Company Overview and News

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.

Headline News

B.C. creator of non-browning Arctic apple plans 'aggressive expansion' after positive U.S. test run

2018-02-17 cbc.ca
Following an "amazing" test run in select U.S. markets, the B.C. creator of the genetically modified, non-browning Arctic apple says an aggressive company expansion is on the horizon, though it will take time for the product to come to Canada. (11-1)

BioXcel Therapeutics Seeks $69 Million U.S. IPO

2018-02-16 seekingalpha
The firm is using the advanced data and AI technologies of its parent company to improve its drug development efforts. (381-3)

XON / Intrexon Corp. / FMR LLC / Fidelity - 3G/A (Passive Investment)

2018-02-13 sec.gov
SCHEDULE 13G Amendment No. 2 INTREXON CORP COMMON STOCK Cusip #46122T102 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #46122T102 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 609,235 Item 6: 0 Item 7: 3,776,301 Item 8: 0 Item 9: 3,776,301 Item 11: 3.128% Item 12: HC Cusip #46122T102 Item 1: Reporting Person - Abigail P.

XON / Intrexon Corp. / FMR LLC / Fidelity - 3G/A (Passive Investment)

2018-02-13 sec.gov
SCHEDULE 13G Amendment No. 2 INTREXON CORP COMMON STOCK Cusip #46122T102 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #46122T102 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 609,235 Item 6: 0 Item 7: 3,776,301 Item 8: 0 Item 9: 3,776,301 Item 11: 3.128% Item 12: HC Cusip #46122T102 Item 1: Reporting Person - Abigail P.

Miller Value Partners Opportunity Equity Q4 2017 Letter: The Value Of Doing Nothing

2018-01-31 seekingalpha
Includes detailed analysis of Miller Value Partners' positions in: OMF, CTL, DISCA, SFIX, VRX, RH, XON, AMZN, QUOT, MNK. (428-6)

CAR-T Developers  Continue To Fly

2018-01-24 seekingalpha
Today, Celgene announced the acquisition of Juno Therapeutics for $9B and CAR-T stocks continued their trajectory higher. (31-4)

XON / Intrexon Corp. / KIRK RANDAL J - SC 13D/A (Activist Investment)

2018-01-22 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC  20549   SCHEDULE 13D (Amendment No. 6)* Under the Securities Exchange Act of 1934 INTREXON CORPORATION (Name of Issuer) Common Stock (Title of Class of Securities) 46122T102 (CUSIP Number) Third Security, LLC 1881 Grove Avenue Radford, Virginia 24141 Attention: Marcus E. Smith, Esq. (540) 633-7900 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) Copy to: John Owen Gwathmey, Esq.

XON / Intrexon Corp. / KIRK RANDAL J - SC 13D/A (Activist Investment)

2018-01-22 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC  20549   SCHEDULE 13D (Amendment No. 6)* Under the Securities Exchange Act of 1934 INTREXON CORPORATION (Name of Issuer) Common Stock (Title of Class of Securities) 46122T102 (CUSIP Number) Third Security, LLC 1881 Grove Avenue Radford, Virginia 24141 Attention: Marcus E. Smith, Esq. (540) 633-7900 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) Copy to: John Owen Gwathmey, Esq.

XON / Intrexon Corp. 8-K (Current Report)

2018-01-19 sec.gov
8-K     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 17, 2018     INTREXON CORPORATION (Exact Name of Registrant as Specified in Charter)       Virginia   001-36042   26-0084895 (State or Other Jurisdiction of Incorporation)   (Commission File Number)   (I.

XON / Intrexon Corp. 424B5 (Prospectus)

2018-01-18 sec.gov
424B5 Table of Contents Pursuant to Rule 424B5 Commission File Number: 333-220326 CALCULATION OF REGISTRATION FEE     Title of each class of securities to be registered   Amount to be Registered(1)   Proposed Maximum Offering Price per Share   Proposed Maximum Aggregate Offering Price(1)(2)   Amount of Registration Fee Common Stock, no par value   6,900,000   $12.50   $86,250,000   $10,738.13     (1) Assumes exercise in full of the underwriters’ option to purchase up to 900,000 additional shares

Your Daily Pharma Scoop: Juno Surges On Takeover Rumors, AEterna Zentaris Achieves Another Milestone, Spark Granted ODD

2018-01-18 seekingalpha
Juno shares surged on WSJ report that Celgene is in talks to acquire the CAR-T company. (193-2)

XON / Intrexon Corp. 424B5 (Prospectus)

2018-01-16 sec.gov
424B5 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-220326   The information in this preliminary prospectus supplement is not complete and may be changed. This preliminary prospectus supplement and the accompanying base prospectus are not an offer to sell these securities, and are not soliciting an offer to buy these securities, in any jurisdiction where the offer or sale is not permitted.

XON / Intrexon Corp. 8-K (Current Report)

2018-01-10 sec.gov
8-K     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 10, 2018     INTREXON CORPORATION (Exact Name of Registrant as Specified in Charter)       Virginia   001-36042   26-0084895 (State or Other Jurisdiction of Incorporation)   (Commission File Number)   (I.

XON / Intrexon Corp. FORM 8-K (Current Report)

2018-01-08 sec.gov
Form 8-K     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 8, 2018     INTREXON CORPORATION (Exact Name of Registrant as Specified in Charter)       Virginia   001-36042   26-0084895 (State or Other Jurisdiction of Incorporation)   (Commission File Number)   (I.

XON / Intrexon Corp. / Sabby Management, LLC - SABBY 13G-A XON 1.04.18 (Passive Investment)

2018-01-04 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.2)* Intrexon Corp. (formerly GenVec, Inc.) (Name of Issuer) Common Stock (Title of Class of Securities) 46122T102 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [_] Rule 13d-1(b) [X] Rule 13d-1(c) [_] Rule 13d-1(d) __________ *Th


CUSIP: 46122T102